Naveen Pemmaraju: Honored to spend some great quality time with Richard Silver this evening at MPN Hero 2023

Naveen Pemmaraju, made the following post on X/Twitter:

“ASH 23 Wow! What an evening. Honored to spend some great quality time in a scintillating discussion about the future of interferon and interferon-based combinations and Disease Modification with Richard Silver this evening at MPN Hero 2023!”

Source: Naveen Pemmaraju/X

Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network. He is also the Leukemia Hematology/Oncology Course Director. His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML. He has been named MDACC’s, Department of Leukemia, Inaugural Director of BPDCN Program, in 2020, which is one of the world’s most active BPDCN research programs. Dr. Pemmaraju is the recipient of the MDACC Gerald P. Bodey Award for Excellence in Education in 2020. He is a well-known social media influencer and advocate.